Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis

Oncogene

Volumn 35, Issue 30, 2016, Pages 3919-3931

  Yang, W ^a,b   Du, W W ^a,b   Li, X ^a,b,c   Yee, A J ^a   Yang, B B ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c GUANGDONG INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CIRCULAR RNA; MESSENGER RNA; MICRORNA; MICRORNA 136; MICRORNA 138; MICRORNA 149; MICRORNA 22; MICRORNA 3614; MICRORNA 3622; MICRORNA 433; MICRORNA 762; RNA; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; UNTRANSLATED RNA; FOXO3 PROTEIN, HUMAN; RNA, CIRCULAR;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOGENE; SURVIVAL; ANIMAL; CELL SURVIVAL; FEMALE; GENETICS; MOUSE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; FORKHEAD BOX PROTEIN O3; HUMANS; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PSEUDOGENES; RNA;

EID: 84949870493     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.460     Document Type: Article

References (51)

1. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010; 465: 1033-1038.
2. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK et al. Natural RNA circles function as efficient microRNA sponges. Nature 2013; 495: 384-388.
3. Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM et al. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature 2014; 505: 212-217.
4. Anderson MJ, Viars CS, Czekay S, Cavenee WK, Arden KC. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 1998; 47: 187-199.
5. Salazar M, Lorente M, Garcia-Taboada E, Perez Gomez E, Davila D, Zuniga-Garcia P et al. Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation. Cell Death Differ 2015; 22: 131-144.
6. Bowman A, Nusse R. Location, location, location: FoxM1 mediates beta-catenin nuclear translocation and promotes glioma tumorigenesis. Cancer Cell 2011; 20: 415-416.
7. Nestal de Moraes G, Bella L, Zona S, Burton MJ, Lam EW. Insights into a critical role of the FOXO3a-FOXM1 axis in DNA damage response and genotoxic drug resistance. Curr Drug Targets 2014; 15: 1-14.
8. Sykes SM, Lane SW, Bullinger L, Kalaitzidis D, Yusuf R, Saez B et al. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 2011; 146: 697-708.
9. Scodelaro Bilbao P, Boland R. Extracellular ATP regulates FoxO family of transcription factors and cell cycle progression through PI3K/Akt in MCF-7 cells. Biochim Biophys Acta 2013; 1830: 4456-4469.
10. Moriishi T, Kawai Y, Komori H, Rokutanda S, Eguchi Y, Tsujimoto Y et al. Bcl2 deficiency activates FoxO through Akt inactivation and accelerates osteoblast differentiation. PLoS One 2014; 9: e86629.
11. Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007; 7: 847-859.
12. Cho EC, Kuo ML, Liu X, Yang L, Hsieh YC, Wang J et al. Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients. Oncotarget 2014; 5: 4834-4844.
13. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-Associated transcription factor. Proc Natl Acad Sci USA 2009; 106: 1814-1819.
14. Li J, Li P, Chen T, Gao G, Chen X, Du Y et al. Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer. Tumour Biol 2014; 36: 685-692.
15. Boulias K, Horvitz HR. The C. elegans microRNA mir-71 acts in neurons to promote germline-mediated longevity through regulation of DAF-16/FOXO. Cell Metab 2012; 15: 439-450.
16. Seitz H, Youngson N, Lin SP, Dalbert S, Paulsen M, Bachellerie JP et al. Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. Nat Genet 2003; 34: 261-262.
17. Shatseva T, Lee DY, Deng Z, Yang BB. MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J Cell Sci 2011; 124: 2826-2836.
18. Fang L, Du WW, Yang W, Rutnam ZJ, Peng C, Li H et al. MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle 2012; 11: 4352-4365.
19. Siragam V, Rutnam ZJ, Yang W, Fang L, Luo L, Yang X et al. MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11. Oncotarget 2012; 3: 1370-1385.
20. Rutnam ZJ, Yang BB. The non-coding 3′ UTR of CD44 induces metastasis by regulating extracellular matrix functions. J Cell Sci 2012; 125: 2075-2085.
21. Wang CH, Lee DY, Deng Z, Jeyapalan Z, Lee SC, Kahai S et al. MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS One 2008; 3: e2420.
22. Shan SW, Lee DY, Deng Z, Shatseva T, Jeyapalan Z, Du WW et al. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol 2009; 11: 1031-1038.
23. Lee DY, Deng Z, Wang CH, Yang BB. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA 2007; 104: 20350-20355.
24. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261.
25. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-688.
26. Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities. RNA 2010; 16: 2043-2050.
27. Lee DY, Shatseva T, Jeyapalan Z, Du WW, Deng Z, Yang BB. A 3′-untranslated region (3′UTR) induces organ adhesion by regulating miR-199afunctions. PLoS One 2009; 4: e4527.
28. Jeyapalan Z, Deng Z, Shatseva T, Fang L, He C, Yang BB. Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res 2011; 39: 3026-3041.
29. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147: 358-369.
30. Nam Y, Chen C, Gregory RI, Chou JJ, Sliz P. Molecular basis for interaction of let-7 microRNAs with Lin28. Cell 2011; 147: 1080-1091.
31. Rutnam ZJ, Du WW, Yang W, Yang X, Yang BB. The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs. Nat Commun 2014; 5: 2914.
32. Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014; 505: 344-352.
33. Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol 2014; 32: 453-461.
34. AbouHaidar MG, Venkataraman S, Golshani A, Liu B, Ahmad T. Novel coding, translation, and gene expression of a replicating covalently closed circular RNA of 220 nt. Proc Natl Acad Sci USA 2014; 111: 14542-14547.
35. Haimovich G, Medina DA, Causse SZ, Garber M, Millan-Zambrano G, Barkai O et al. Gene expression is circular: factors for mRNA degradation also foster mRNA synthesis. Cell 2013; 153: 1000-1011.
36. Wilusz JE, Sharp PA. Molecular biology. A circuitous route to noncoding RNA. Science 2013; 340: 440-441.
37. Hentze MW, Preiss T. Circular RNAs: splicing′s enigma variations. EMBO J 2013; 32: 923-925.
38. Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013; 495: 333-338.
39. Capel B, Swain A, Nicolis S, Hacker A, Walter M, Koopman P et al. Circular transcripts of the testis-determining gene Sry in adult mouse testis. Cell 1993; 73: 1019-1030.
40. Du WW, Yang W, Fang L, Xuan J, Li H, Khorshidi A et al. miR-17 extends mouse lifespan by inhibiting senescence signaling mediated by MKP7. Cell Death Dis 2014; 5: e1355.
41. Bartell SM, Kim HN, Ambrogini E, Han L, Iyer S, Serra Ucer S et al. FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation. Nat Commun 2014; 5: 3773.
42. Haeusler RA, Hartil K, Vaitheesvaran B, Arrieta-Cruz I, Knight CM, Cook JR et al. Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nat Commun 2014; 5: 5190.
43. Keniry M, Pires MM, Mense S, Lefebvre C, Gan B, Justiano K et al. Survival factor NFIL3 restricts FOXO-induced gene expression in cancer. Genes Dev 2013; 27: 916-927.
44. Kloet DE, Burgering BM. The PKB/FOXO switch in aging and cancer. Biochim Biophys Acta 2011; 1813: 1926-1937.
45. Chen Q, Ganapathy S, Singh KP, Shankar S, Srivastava RK. Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PLoS One 2010; 5: e15288.
46. Cocquerelle C, Mascrez B, Hetuin D, Bailleul B. Mis-splicing yields circular RNA molecules. FASEB J 1993; 7: 155-160.
47. Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013; 19: 141-157.
48. Yang BL, Cao L, Kiani C, Lee V, Zhang Y, Adams ME et al. Tandem repeats are involved in G1 domain inhibition of versican expression and secretion and the G3 domain enhances glycosaminoglycan modification and product secretion via the complement-binding protein-like motif. J Biol Chem 2000; 275: 21255-21261.
49. Cao L, Yao Y, Lee V, Kiani C, Spaner D, Lin Z et al. Epidermal growth factor induces cell cycle arrest and apoptosis of squamous carcinoma cells through reduction of cell adhesion. J Cell Biochem 2000; 77: 569-583.
50. LaPierre DP, Lee DY, Li SZ, Xie YZ, Zhong L, Sheng W et al. The ability of versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Res 2007; 67: 4742-4750.
51. Yang X, Du WW, Li H, Liu F, Khorshidi A, Rutnam ZJ et al. Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion. Nucleic Acids Res 2013; 41: 9688-9704.